Joseph Vittiglio is Chief Business Officer & GC at AMAG PHARMACEUTICALS, INC. (AMAG). They have made 3 open-market trades across 2 companies since 2013, most recently 2026-03-01.
CIK 0001551776
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLUE | SELL | 2025-02-03 | 2025-02-05 | $7.39 | $2K | +1.3% | -43.1% | -45.4% |
| BLUE | SELL | 2024-02-05 | 2024-02-06 | $0.90 | $5K | +8.5% | +54.3% | +6.4% |
| FNCH | SELL | 2022-10-21 | 2022-10-25 | $1.39 | $5K | -13.7% | -37.0% | -65.6% |
| AMAG | SELL · 10b5-1 | 2019-03-07 | 2019-03-11 | $14.01 | $20K | -0.3% | +1.3% | -26.2% |
| AMAG | SELL · 10b5-1 | 2018-03-06 | 2018-03-06 | $20.80 | $16K | -5.0% | -0.2% | +18.9% |
| AMAG | SELL · 10b5-1 | 2017-08-29 | 2017-08-30 | $16.75 | $21K | +21.2% | +10.1% | -15.5% |
| AVEO | SELL · 10b5-1 | 2015-01-07 | 2015-01-08 | $0.80 | $4K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL · 10b5-1 | 2014-01-30 | 2014-01-30 | $1.64 | $9K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL · 10b5-1 | 2013-01-28 | 2013-01-28 | $7.77 | $3K | -20.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.